Delivery Order SPE2DB22D1106-SPE2DB25FELS2

Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,636.00, is for the delivery of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,648.20, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The contract is a firm fixed price type with a period of performance through December 19, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,161.68, is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product, with a completion date of May 1, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,327.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, with a performance period through May 9, 2025. The contract is not set aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,220.94, is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,544.00, is for the delivery of GAMUNEX-C 40 gram/400 mL vials, a pharmaceutical product, with a performance period extending through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, a medical product used for various healthcare purposes. The contract has a firm fixed price and a ceiling value of $13,963.20, with a period of performance through April 28, 2025. This award is not set-aside and represents an open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,022.70, is for the delivery of GAMUNEX-C, a 40 gram/400 ml vial of pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 23, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,530.00 contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a performance period through December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $56,646.72, is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period extending through May 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FELS2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,180.14, is for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period that extends through May 23, 2025. This contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:12 AM